An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Healthcare Supplier and Manufacturer AliMed, Inc. Names Adam S. Epstein as Chief Executive Officer
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
AliMed, Inc. has appointed Adam S. Epstein as the new Chief Executive Officer, effective immediately. Epstein, previously the Chief Commercial Officer, aims to strengthen the company's operations and product portfolio serving leading healthcare providers. AliMed, known for its innovative medical supplies, has focused on growth through partnerships with national GPOs and IDNs while enhancing product development. Under Epstein's leadership, AliMed seeks to improve patient outcomes through its comprehensive healthcare offerings.
Positive
Adam S. Epstein's promotion as CEO could enhance leadership stability and strategic direction.
Commitment to product development with a strong pipeline may drive future sales growth.
Building contracted positions with national GPOs and IDNs can expand market access.
Negative
None.
DEDHAM, Mass.--(BUSINESS WIRE)--
Healthcare product manufacturer and distributor, AliMed, Inc. (www.alimed.com) announced today the promotion of Adam S. Epstein, 51, to the position of Chief Executive Officer, effective immediately. In his new role, Epstein will oversee the company’s general operations and its diversified portfolio of products sold to a majority of the country’s leading healthcare providers.
AliMed CEO, Adam S. Epstein (Photo: Business Wire)
In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth. The company has also reinvested in product development and has a strong pipeline of new products now commercializing for use in both acute and post-acute care settings.
AliMed’s strong brand identity is synonymous with 50-years of innovative products and customizations developed to address a range of healthcare challenges. "Adam has done a great job strengthening our relationships with major customers and key sales partners," said AliMed’s Chair of the Board and President, Alexandra Cherubini. "He is committed to remaining relevant to our key partners and inspiring customer loyalty to our brand. He is a tremendous leader and I’m confident he will guide our business to even greater success."
Epstein has worked at AliMed since late 2019. Prior to that, he held senior roles at UFP Technologies (NASDAQ: UFPT) and Dielectrics, Inc. leading the development, commercialization, and sales of medical products and devices.
"I am excited about continuing to build the business with our talented and dedicated team of professionals,” Epstein said. "The important work AliMed does, enables caregivers to positively impact their patients’ lives. Our mission is helping people help people. We’re proud to be doing that on many fronts, through our broad product portfolio, signature service, and community engagement program, AliCares." Epstein holds degrees from the University of Rochester and the Isenberg School of Management at UMASS.
AliMed Inc. headquartered in Dedham, MA and founded over 50 years ago by Barbara and Julian Cherubini, built its reputation on high-value, differentiated offerings and exceptional service. This specialty medical supplies manufacturer and distributor has on-site customization capabilities for both domestic and international care providers, dealers, and distributors. AliMed’s broad portfolio of healthcare products is designed to improve patient outcomes and experience, serving needs from “hospital to home”. To learn more Visit AliMed.com
